A team of scientists led by Liang Ge from Tsinghua University have identified a chaperonin subunit CCT2 as a new type of aggrephagy receptor which specifically accelerates the autophagic clearance of solid aggregates independent of ubiquitination, providing a promising therapeutic target for neurodegenerative diseases.
